Hydroxyapatite Crystal Deposition Disease of the Shoulder: A Review of Cases and LiteratureFunding None.
22. Januar 2019 (online)
Hydroxyapatite crystal deposition diseases (HADDs) are characterized by deposition of insoluble crystals within the joints and periarticular soft tissues, initiating inflammatory destructive reaction. Calcium hydroxyapatite (CHA) is the most common type of calcium in human bone and is also the most common pathologic calcification found in the body. There are three phases of the disease: silent, mechanical, and adhesive phases. The shoulder is the most common site of HADD. CHA crystals are non-birefringent in polarized light. Radiographic characteristics include homogenous, amorphous densities without trabeculations that are variable in size, ovoid, triangular, or linear. The first imaging modalities to identify calcific tendinitis (CT) were X-ray and ultrasound, as calcium deposits are readily identifiable on both. Treatment is chiefly conservative, including nonsteroidal anti-inflammatory drugs (NSAIDs), local heat application, and physiotherapy. Local corticosteroid injections may also be of benefit. When intra-articular, CHA crystals can cause joint destruction such as “ Milwaukee shoulder.” In the acute symptomatic phase of HADD, called acute calcific periarthritis, soft tissue and osseous edema can be present and needs to be differentiated from infection, tumor, and trauma.
- 1 Scibek JS, Carcia CR. Presentation and conservative management of acute calcific tendinopathy: a case study and literature review. J Sport Rehabil 2012; 21 (04) 334-342
- 2 Oliva F, Via AG, Maffulli N. Calcific tendinopathy of the rotator cuff tendons. Sports Med Arthrosc Rev 2011; 19 (03) 237-243
- 3 ElShewy MT. Calcific tendinitis of the rotator cuff. World J Orthop 2016; 7 (01) 55-60
- 4 Louwerens JK, Sierevelt IN, van Hove RP, van den Bekerom MP, van Noort A. Prevalence of calcific deposits within the rotator cuff tendons in adults with and without subacromial pain syndrome: clinical and radiologic analysis of 1219 patients. J Shoulder Elbow Surg 2015; 24 (10) 1588-1593
- 5 Diehl P, Gerdesmeyer L, Gollwitzer H, Sauer W, Tischer T. [Calcific tendinitis of the shoulder] [in German]. Orthopade 2011; 40 (08) 733-746
- 6 Hofstee DJ, Gosens T, Bonnet M, De Waal MalefijtJ. Calcifications in the cuff: take it or leave it?. Br J Sports Med 2007; 41 (11) 832-835
- 7 Chiou HJ, Chou YH, Wu JJ, Hsu C, Huang DY, Chang CY. Evaluation of calcific tendonitis of the rotator cuff: role of color Doppler ultrasonography. J Ultrasound Med 2002; 21 (03) 289-295 quiz 296–297
- 8 Maier M, Stäbler A, Schmitz C. et al. On the impact of calcified deposits within the rotator cuff tendons in shoulders of patients with shoulder pain and dysfunction. Arch Orthop Trauma Surg 2001; 121 (07) 371-378
- 9 Loew M, Sabo D, Wehrle M, Mau H. Relationship between calcifying tendinitis and subacromial impingement: a prospective radiography and magnetic resonance imaging study. J Shoulder Elbow Surg 1996; 5: 314-319
- 10 Gatt DL, Charalambous CP. Ultrasound-guided barbotage for calcific tendonitis of the shoulder: a systematic review including 908 patients. Arthroscopy 2014; 30 (09) 1166-1172
- 11 Genta MS, Gabay C. Images in clinical medicine. Milwaukee shoulder. N Engl J Med 2006; 354 (02) e2
- 12 Rui YF, Lui PP, Chan LS, Chan KM, Fu SC, Li G. Does erroneous differentiation of tendon-derived stem cells contribute to the pathogenesis of calcifying tendinopathy?. Chin Med J (Engl) 2011; 124 (04) 606-610